Ceapro Inc.
CRPOF · OTC
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
|---|---|---|---|---|
| Revenue | $2,774 | $1,651 | $2,619 | $1,869 |
| % Growth | 68% | -37% | 40.1% | – |
| Cost of Goods Sold | $1,713 | $1,553 | $1,539 | $798 |
| Gross Profit | $1,061 | $98 | $1,080 | $1,070 |
| % Margin | 38.3% | 5.9% | 41.2% | 57.3% |
| R&D Expenses | $1,376 | $666 | $585 | $927 |
| G&A Expenses | $2,230 | $2,300 | $1,973 | $1,625 |
| SG&A Expenses | $2,134 | $2,307 | $1,985 | $1,639 |
| Sales & Mktg Exp. | $5 | $7 | $12 | $13 |
| Other Operating Expenses | $0 | -$215 | $0 | $0 |
| Operating Expenses | $3,510 | $2,871 | $2,569 | $2,565 |
| Operating Income | -$2,449 | -$2,774 | -$1,521 | -$1,528 |
| % Margin | -88.3% | -168% | -58.1% | -81.7% |
| Other Income/Exp. Net | $2 | $155 | $164 | $25 |
| Pre-Tax Income | -$2,446 | -$2,619 | -$1,325 | -$1,470 |
| Tax Expense | -$556 | -$489 | -$285 | -$316 |
| Net Income | -$1,890 | -$2,130 | -$1,040 | -$1,154 |
| % Margin | -68.1% | -129% | -39.7% | -61.8% |
| EPS | -0.024 | -0.027 | -0.013 | -0.015 |
| % Growth | 11.4% | -104.5% | 10.1% | – |
| EPS Diluted | -0.024 | -0.027 | -0.013 | -0.015 |
| Weighted Avg Shares Out | 78,293 | 78,293 | 78,291 | 78,253 |
| Weighted Avg Shares Out Dil | 78,293 | 78,293 | 78,291 | 78,253 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $85 | $0 | $0 |
| Interest Expense | $29 | $30 | $31 | $33 |
| Depreciation & Amortization | $484 | $488 | $487 | $486 |
| EBITDA | -$1,932 | -$2,100 | -$890 | -$898 |
| % Margin | -69.7% | -127.2% | -34% | -48.1% |